Mark Lamotte Selected Research

Venous Thromboembolism

1/2016	Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
10/2015	The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Lamotte Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 03/2022 - 10/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 01/2006
4	Coronary Disease (Coronary Heart Disease) 06/2013 - 01/2006
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2016
3	Myocardial Infarction 01/2007 - 01/2006
3	Hypertension (High Blood Pressure) 08/2004 - 02/2002
2	Obesity 06/2021 - 02/2002
2	Pulmonary Embolism 01/2016 - 10/2015
2	Venous Thromboembolism 01/2016 - 10/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 10/2015
2	Atrial Fibrillation 05/2014 - 11/2007
2	Sudden Death 12/2006 - 01/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2004 - 10/2003
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2004 - 10/2003
1	Diabetes Mellitus 12/2021
1	Prediabetic State (Prediabetes) 06/2021
1	Human Influenza (Influenza) 01/2021
1	Heart Failure 09/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 04/2019
1	Disease Progression 01/2019
1	Hemophilia A (Haemophilia) 12/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2018
1	Schizophrenia (Dementia Praecox) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Chronic Hepatitis C 12/2014
1	Vascular Diseases (Vascular Disease) 06/2013
1	Neuralgia (Stump Neuralgia) 01/2013
1	Pain (Aches) 01/2013
1	Neoplasms (Cancer) 01/2012
1	Anemia 01/2012
1	Breast Neoplasms (Breast Cancer) 11/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2010
1	Febrile Neutropenia 11/2010
1	Osteoarthritis 01/2010

Drug/Important Bio-Agent (IBA)

8	empagliflozinIBA 03/2022 - 12/2019
6	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 09/2018
4	Metformin (Glucophage)FDA LinkGeneric 03/2022 - 09/2020
4	Insulin (Novolin)FDA Link 12/2021 - 09/2018
3	semaglutideIBA 03/2022 - 09/2020
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2022 - 09/2020
3	Liraglutide FDA Link 12/2021 - 05/2021
3	SodiumIBA 05/2021 - 12/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2007 - 01/2006
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 02/2002
2	Glucagon (Glukagon)FDA Link 12/2021 - 05/2021
2	Sitagliptin Phosphate (Januvia)FDA Link 08/2021 - 12/2019
2	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2021 - 12/2019
2	GoldIBA 01/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 09/2018 - 06/2013
2	Dabigatran FDA Link 01/2016 - 10/2015
2	Pharmaceutical PreparationsIBA 05/2014 - 11/2007
2	Atorvastatin (Lipitor)FDA Link 06/2013 - 08/2008
2	LipidsIBA 06/2013 - 08/2008
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2006 - 01/2006
2	Irbesartan FDA LinkGeneric 08/2004 - 10/2003
2	CreatinineIBA 08/2004 - 10/2003
1	Sodium-Glucose Transport ProteinsIBA 03/2022
1	insulin degludecIBA 12/2021
1	Insulin Glargine (Lantus)FDA Link 12/2021
1	lixisenatideIBA 12/2021
1	IDegLiraIBA 12/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 08/2021
1	A-factor (Streptomyces)IBA 06/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	glimepiride (Amarel)FDA LinkGeneric 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2020
1	CanagliflozinIBA 01/2020
1	saxagliptin FDA Link 12/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2019
1	Prothrombin (Factor II)IBA 12/2018
1	Factor VIIa (Activated Factor VII)IBA 12/2018
1	recombinant FVIIa (rFVIIa)FDA Link 12/2018
1	ElementsIBA 01/2017
1	Muscarinic AntagonistsIBA 01/2016
1	RivaroxabanIBA 01/2016
1	iodixanol (Visipaque)FDA Link 01/2016
1	aclidinium bromideIBA 01/2016
1	Vitamin K FDA Link 01/2016
1	Contrast MediaIBA 01/2016
1	Formoterol Fumarate (Oxis)FDA Link 01/2016
1	Warfarin (Coumadin)FDA LinkGeneric 10/2015
1	Ribavirin (Virazole)FDA LinkGeneric 12/2014
1	telaprevirIBA 12/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 12/2014
1	Anti-Arrhythmia AgentsIBA 05/2014
1	perindopril drug combination indapamideIBA 06/2013
1	Gliclazide (Diamicron)IBA 06/2013
1	Pregabalin (Lyrica)FDA Link 01/2013
1	Epoetin Alfa (Epogen)FDA Link 01/2012
1	epoetin betaIBA 01/2012
1	HematinicsIBA 01/2012
1	Darbepoetin alfa (Aranesp)FDA Link 01/2012
1	Docetaxel (Taxotere)FDA Link 11/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2010

Therapy/Procedure

6	Therapeutics 12/2021 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2012 - 11/2010
2	Secondary Prevention 12/2006 - 01/2006
1	Transcatheter Aortic Valve Replacement 04/2019
1	Cryosurgery 05/2014
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2010